One of China’s leading generic pharmaceutical companies has purchased the rights to commercialise an experimental drug developed by the Chinese military for treating Ebola, though medical experts said the drug is still at an early stage of development.
manbetx3.0 一家领先的仿制药公司买下了manbetx3.0 军方研发的一种实验性埃博拉药物的商业化权利，尽管医学专家们表示，这种药物仍处于早期开发阶段。
您已阅读6%（315字），剩余94%（5246字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。